Vivos Therapeutics任命Roman Franklin为首席财务官,自2026年7月31日起生效——SEC文件披露

美股速递
Aug 04

Vivos Therapeutics(股票代码:VVOS)已正式任命Roman Franklin担任公司首席财务官一职。这一任命将从2026年7月31日正式生效,相关详情已通过美国证券交易委员会(SEC)的文件予以披露。此次人事调整标志着公司财务管理层迎来新的掌舵者。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10